Biomarkers related to kidney function and methods involving their use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 1, 2020
Grant Date -
Jan 18, 2018
app pub date -
Jan 7, 2016
filing date -
Jan 7, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method for diagnosing in a subject Acute Kidney Injury or a related or analogous disease state. The method comprises the steps of a) providing a sample taken from the subject: b) analysing the sample from the subject to determine the level of a biomarker selected from certain atomic species; and c) comparing the level of the biomarker in the sample to a reference level of the biomarker that is characteristic of a healthy subject, eg a subject having normal renal function. An elevated level of the biomarker in the sample relative to the reference level is indicative of Acute Kidney Injury or a related or analogous disease state. The invention also relates to the use of an atomic species selected from those in Table 1 as a biomarker for Acute Kidney Injury or a related or analogous disease state, and test kits comprising an analytical element sensitive to those biomarkers.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2016 Application Filing Year
- G01N Class
- 12375 Applications Filed
- 8515 Patents Issued To-Date
- 68.81 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- G01N Class
- 0 % this patent is cited more than
- 5 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 1, 2028 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 1, 2032 |
